Most of what the general public “knows” about cholesterol is wrong, and that’s the way drug companies like it

Myths for sale

It has to be the biggest propaganda campaign in the history of medicine.

Don’t get me wrong…there have been a lot to choose from. But this one wins, hands down.

Because it’s a scam that got people to spend over $125 BILLION on a drug they didn’t need.

And that’s just one of the drugs in this class. If you add all the different brands together, it’s probably closer to half a TRILLION dollars wasted.

And all because we never needed to lower cholesterol.

That “bad” cholesterol number that your doctor wants to see lower and lower is actually the wrong thing to measure to see if you’re at risk. What matters is the particle size and density.

Cholesterol is like a snowball in your bloodstream. If it’s light and “fluffy,” there’s nothing to worry about. But if it’s packed and dense…well…you don’t want to get hit with it.

So why have we been focused on the level instead of the density?

You know the answer: To get people on cholesterol-lowering drugs for a lifetime.

But now that some heavy-hitting patents have expired, everyone is scrambling for the next big thing.

And you won’t believe what they’ve cooked up.

How low can you go?

First, let’s clear up one of the biggest myths. That cholesterol is actually bad for you.

Really? The AMA and the drug companies know better than our Maker what we need?

Cholesterol is actually GOOD for your arteries. It repairs arteries and prevents internal bleeding.

Cholesterol is also necessary for proper functioning of your brain, your eyes, your muscles, and other key functions that you would never want to compromise. When you walk into the sunlight, guess what your skin uses to help manufacture vitamin D? Yep. Cholesterol.

But completely contrary to that healthy reality, drug companies, with help from the AMA and their lemmings at the FDA, have spent the past 25 years convincing everyone that cholesterol is a monster. Especially LDL. So according to drug marketers, the only logical course is to drive LDL down…to the lowest possible level.

How low? Here’s the future of cholesterol “health care”…

Three drug companies are racing to be the first to create a drug that mimics the effects of a rare gene mutation. That mutation happens to drive LDL cholesterol down into the TEENS.

Drug companies have spent years carving out a market for low cholesterol. So they see this new approach as a potential return to the blockbuster glory days of Lipitor

If they succeed in getting this drug on the market, it might be beneficial for the very few people with exceedingly high and dense LDL. But that’s a small fraction of the population. And yet, one company has already devoted THREE factories to production of this drug. Obviously, they intend to sell boatloads.

Pfizer is one of the companies testing the drug. In their trials, they are interrupting treatment when LDL levels reach 25 or lower. The New York Times reported… “The people seemed fine, but the company got nervous.”

They have good reason to be nervous. Patients will “seem fine” at first. Over time, excessively low LDL levels will destroy their health. Especially in older people, who will develop cataracts, muscle damage, and memory loss.

But that will be success by drug company standards. Ridiculously low LDL levels and ridiculously high profits.

Sources:
“Rare Mutation Ignites Race for Cholesterol Drug” Gina Kolata, The New York Times, 7/9/13, nytimes.com